CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: implications for cellular immunotherapy of CD20+ malignancy.
Open Access
- 1 August 1998
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 4 (2) , 75-83
- https://doi.org/10.1053/bbmt.1998.v4.pm9763110
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: